noun a type of anemia caused by a genetic mutation
Sickle cell anemia is a genetic blood disorder that affects the shape of red blood cells, leading to health complications such as pain, anemia, and organ damage.
Sickle cell anemia is caused by a mutation in the gene that makes hemoglobin, resulting in abnormal hemoglobin molecules that cause red blood cells to become sickle-shaped.
Studies on sickle cell anemia focus on developing treatments such as gene therapy, bone marrow transplants, and medications to improve symptoms and quality of life for patients.
Sickle cell anemia is a major public health concern in regions where the gene mutation is more prevalent, leading to increased healthcare costs and challenges in managing the disease.
Sickle cell anemia is commonly diagnosed in childhood through newborn screening or when symptoms such as pain crises or infections occur.
Sickle cell anemia is classified as a type of hemolytic anemia, where red blood cells are destroyed faster than they can be produced, leading to a shortage of healthy red blood cells.
Sickle cell anemia is often mentioned in medical articles and research papers written by writers who specialize in health and science topics.
Psychologists may encounter sickle cell anemia when working with patients who have the condition and may need to provide support and coping strategies for dealing with the physical and emotional challenges it presents.
Medical doctors play a key role in diagnosing and treating sickle cell anemia patients, monitoring their health, and providing appropriate medical interventions to manage symptoms and complications.
Genetic counselors work with individuals and families who may be at risk of passing on sickle cell anemia to their children, providing information about genetic testing, inheritance patterns, and reproductive options.
Research scientists study sickle cell anemia to better understand its underlying mechanisms, develop new treatment options, and work towards finding a cure for this genetic disorder.